Derek P. Chew

发表

Impact of a regionalised clinical cardiac support network on mortality among rural patients with myocardial infarction

R. Tavella, R. Tirimacco, P. Tideman, 2014, The Medical journal of Australia.

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016

I. Scott, P. Aylward, T. Briffa, 2016, The Medical journal of Australia.

Intracoronary ECG ST‐segment recovery during primary percutaneous intervention for ST‐segment myocardial infarction: Insights from a cardiac MRI study

I. Meredith, R. Puri, M. Worthley, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents

D. Chew, R. Prakash, Y. Wong, 2010, Current opinion in cardiology.

Variation in coronary angiography rates in Australia: correlations with socio‐demographic, health service and disease burden indices

H. Buchan, D. Braddock, D. Chew, 2016, The Medical journal of Australia.

Instantaneous Decrease in Left Ventricular Afterload during Transcatheter Aortic Valve Implantation Results in Immediate Changes in Left Ventricular Strain

D. Chew, R. Perry, J. Selvanayagam, 2016, Echocardiography.

Cost‐effectiveness of drug‐eluting stents: if only all things were equal

D. Chew, Derek P. Chew, 2005, The Medical journal of Australia.

Clinical care standards: appropriate care everywhere — acute coronary syndromes as an example

D. Chew, Meredith A Page, R. Herkes, 2016, The Medical journal of Australia.

Survival after an acute coronary syndrome: 18‐month outcomes from the Australian and New Zealand SNAPSHOT ACS study

G. Gamble, D. Chew, D. Brieger, 2015, The Medical journal of Australia.

Availability of highly sensitive troponin assays and acute coronary syndrome care: insights from the SNAPSHOT registry

D. Chew, D. Brieger, T. Briffa, 2015, The Medical journal of Australia.

Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.

S. Lehman, C. Papendick, S. Steele, 2023, Heart, lung & circulation.

Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial

L. Sharples, D. Stocken, A. Yan, 2023, BMJ.

Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.

E. Ohman, H. Thiele, Manesh R Patel, 2016, American heart journal.

Potential survival gains in the treatment of myocardial infarction

D. Liew, D. Chew, D. Brieger, 2009, Heart.

Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes

J. Amerena, D. Chew, D. Brieger, 2009, Heart.

Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit

J. Amerena, D. Chew, D. Brieger, 2007, Internal medicine journal.

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.

N. Smedira, R. Hetzer, A. DeAnda, 2004, The American journal of cardiology.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Jeroen J. Bax, J. Mehilli, S. Windecker, 2011, European heart journal.

[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)].

J. Mehilli, S. Windecker, C. Patrono, 2016, Giornale italiano di cardiologia.

Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

S. Pocock, H. White, G. Stone, 2008, Journal of the American College of Cardiology.

Comparison of the management and in‐hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit

I. Ranasinghe, H. White, G. Gamble, 2015, Internal medicine journal.

Diagnosis and management of acute coronary syndromes

J. Eng-Frost, Derek P. Chew, 2021, Australian prescriber.

Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.

E. Topol, A. Lincoff, J. Bittl, 2007, The American journal of cardiology.

Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?

B. Pathik, J. Selvanayagam, A. McGavigan, 2016, Internal medicine journal.

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).

E. Topol, A. Lincoff, R. Harrington, 2004, The American journal of cardiology.

Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year.

P. Jansz, D. Chew, D. Walters, 2014, International journal of cardiology.

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).

E. Topol, T. Henry, A. Lincoff, 2005, The American journal of cardiology.

The REPLACE 1 trial: a pilot study of bivalirudin versus heparin during percutaneous coronary intervention with stenting and GP IIb/IIIa blockade

E. Topol, A. Lincoff, R. Harrington, 2002 .

The Last Mile: Improving Patient Outcomes within Modern Cardiovascular Medicine

D. Chew, Derek P. Chew, 2008 .

GDF‐15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD

Y. Liu, Huadong Zhu, Yuguo Chen, 2023, ESC heart failure.

B. Lewis, J. Mehilli, S. Windecker, 2016 .

Lifestyle counselling targeting infant's mother during the child's first year and offspring weight development until 4 years of age: a follow-up study of a cluster RCT

M. Whitehouse, M. Porter, A. Blom, 2012, BMJ Open.

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.

E. Topol, A. Lincoff, A. Lansky, 2006, American heart journal.

Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist

T. Leiner, L. Hofstra, J. Verjans, 2019, Netherlands Heart Journal.

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016

I. Scott, P. Aylward, T. Briffa, 2016, The Medical journal of Australia.

The Incremental Value of Functional Testing for Acute Chest Pain Assessment in the Context of High-sensitivity Troponin T

C. Papendick, M. Horsfall, Erin Morton, 2023, Journal of Asian Pacific Society of Cardiology.

Potential survival gains in the treatment of myocardial infarction

D. Liew, D. Brieger, C. Astley, 2009, Heart.

Coronary stenting for stable coronary ischaemia: ain't misbehaving, just misunderstood

Sarah Zaman, Derek P. Chew, 2023, The Medical journal of Australia.